Migraine does not affect cognitive decline: results from the Maastricht aging study

M.A. Baars; M.P.J. van Boxtel; J. Jolles

doi:10.1111/j.1526-4610.2009.01572.x

Migraine does not affect cognitive decline: results from the Maastricht aging study

M.A. Baars
, M.P.J. van Boxtel
, J. Jolles

Clinical Child and Family Studies

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Objective.— To investigate the effects of migraine and related pharmacotherapy on cognitive performance and cognitive change over time in a longitudinal population‐based study.

Methods.— Migraineurs (n = 99) and healthy controls (n = 1724) participating in the Maastricht Aging Study were cognitively tested at baseline and after 6 years. Scores on Mini Mental State Examination, immediate and delayed recall tests, and tests for simple and complex speed were compared for both groups. Generalized Estimating Equations analyses were performed to test the longitudinal effects of migraines on cognition. Effects of migraine medication use were also tested.

Results.— Migraine headaches were found to have no effect on any of the cognitive measures. Medication use also had no effect on all cognitive measures.

Conclusions.— No evidence was found that migraine headaches or migraine‐related medication use are risk or protective factors for cognitive dysfunction or cognitive deterioration over time.

Original language	English
Pages (from-to)	176-184
Number of pages	9
Journal	Headache
Volume	50
Issue number	2
Early online date	24 Jan 2010
DOIs	https://doi.org/10.1111/j.1526-4610.2009.01572.x
Publication status	Published - Feb 2010

Bibliographical note

Online Accepted 15-10-2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 10 Reduced Inequalities

Access to Document

10.1111/j.1526-4610.2009.01572.x

Persistent URL (handle)

Persistent link

Cite this

@article{be603aedcdb6458a8b5618fd6c7e044f,

title = "Migraine does not affect cognitive decline: results from the Maastricht aging study",

abstract = "Objective.— To investigate the effects of migraine and related pharmacotherapy on cognitive performance and cognitive change over time in a longitudinal population‐based study. Methods.— Migraineurs (n = 99) and healthy controls (n = 1724) participating in the Maastricht Aging Study were cognitively tested at baseline and after 6 years. Scores on Mini Mental State Examination, immediate and delayed recall tests, and tests for simple and complex speed were compared for both groups. Generalized Estimating Equations analyses were performed to test the longitudinal effects of migraines on cognition. Effects of migraine medication use were also tested. Results.— Migraine headaches were found to have no effect on any of the cognitive measures. Medication use also had no effect on all cognitive measures. Conclusions.— No evidence was found that migraine headaches or migraine‐related medication use are risk or protective factors for cognitive dysfunction or cognitive deterioration over time.",

author = "M.A. Baars and \{van Boxtel\}, M.P.J. and J. Jolles",

note = "Online Accepted 15-10-2009",

year = "2010",

month = feb,

doi = "10.1111/j.1526-4610.2009.01572.x",

language = "English",

volume = "50",

pages = "176--184",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Migraine does not affect cognitive decline

T2 - results from the Maastricht aging study

AU - Baars, M.A.

AU - van Boxtel, M.P.J.

AU - Jolles, J.

N1 - Online Accepted 15-10-2009

PY - 2010/2

Y1 - 2010/2

N2 - Objective.— To investigate the effects of migraine and related pharmacotherapy on cognitive performance and cognitive change over time in a longitudinal population‐based study. Methods.— Migraineurs (n = 99) and healthy controls (n = 1724) participating in the Maastricht Aging Study were cognitively tested at baseline and after 6 years. Scores on Mini Mental State Examination, immediate and delayed recall tests, and tests for simple and complex speed were compared for both groups. Generalized Estimating Equations analyses were performed to test the longitudinal effects of migraines on cognition. Effects of migraine medication use were also tested. Results.— Migraine headaches were found to have no effect on any of the cognitive measures. Medication use also had no effect on all cognitive measures. Conclusions.— No evidence was found that migraine headaches or migraine‐related medication use are risk or protective factors for cognitive dysfunction or cognitive deterioration over time.

AB - Objective.— To investigate the effects of migraine and related pharmacotherapy on cognitive performance and cognitive change over time in a longitudinal population‐based study. Methods.— Migraineurs (n = 99) and healthy controls (n = 1724) participating in the Maastricht Aging Study were cognitively tested at baseline and after 6 years. Scores on Mini Mental State Examination, immediate and delayed recall tests, and tests for simple and complex speed were compared for both groups. Generalized Estimating Equations analyses were performed to test the longitudinal effects of migraines on cognition. Effects of migraine medication use were also tested. Results.— Migraine headaches were found to have no effect on any of the cognitive measures. Medication use also had no effect on all cognitive measures. Conclusions.— No evidence was found that migraine headaches or migraine‐related medication use are risk or protective factors for cognitive dysfunction or cognitive deterioration over time.

U2 - 10.1111/j.1526-4610.2009.01572.x

DO - 10.1111/j.1526-4610.2009.01572.x

M3 - Article

SN - 0017-8748

VL - 50

SP - 176

EP - 184

JO - Headache

JF - Headache

IS - 2

ER -

Migraine does not affect cognitive decline: results from the Maastricht aging study

Abstract

Bibliographical note

UN SDGs

Access to Document

Persistent URL (handle)

Fingerprint

Cite this